Sun Pharmaceutical Industries will acquire New Jersey-based Organon & Co in an all-cash deal that values the U.S. company at $11.75 billion. Sun Pharmaceutical will buy all outstanding shares of ...
Sun Pharma will pay $14.00 per share cash for Organon, targeting early-2027 close subject to regulatory and shareholder approvals, in what is positioned as India’s largest pharma deal. Organon ...
Sun Pharmaceuticals, the largest pharmaceutical company in India has just announced a deal that places it firmly on the global stage. It is to now figure among the top 25 global pharmaceutical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results